A whole proteomic analysis in MIN6 cells demonstrated that T-068677 significantly degrades a representative autophagic substrate SQSTM1 (log2Fold Change = -1.41, p = 0.020)
Weight loss: Slow to stalled completely
This product is not evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease
Federal agencies faced major funding cuts, including fewer grants for medical research
Chitosan-based gastrointestinal delivery systems
"We don't know for sure if these [initial] results will hold up in a randomized clinical trial," Bernard Fuemmeler, coauthor of the large breast cancer study, and associate director of population science at the VCU Massey Comprehensive Cancer Center, told Scientific American